Our long term goal is to determine the role that pMGA hemagglutinins play in Mycoplasma gallisepticum F-strain (termed as F-strain for brevity) persistence in poultry. To do this however, we first had to identify the pMGA genes expressed by an isolate of the F-strain. To identify F-strain pMGA genes, a genomic library was constructed in bacteriophage lambda and screened with polyclonal antisera raised against F-strain surface antigens capable of inhibiting agglutination of chicken red blood cells. One phage clone was identified, designated 8 9, which remained positive through additional rounds o f screening and was sequenced. Sequence data analysis predicted one complete and two partial open reading frames (ORF) arranged in tandem within the 4.5 kb genomic insert, termed ORF 9.1, ORF 9.2 and ORF 9.3, which showed significant homology to the pMGA gene family of M. gallisepticum. The number of GAA trinucleotide repeats in the intergenic region of 9.3 ORF suggested that this ORF is expressed. The pMGA cDNAs amplified from the F-strain showed significant homology to the 9.3 ORF. One set of cDNAs however, differed from the 9.3 ORF sequence by a repeat of the sequence "AACCAAA" in the 5' end. We conclude that the F-strain vaccine isolate expresses pMGA gene variants, similar to what has been described in field strains of M. gallisepticum.
Introduction
Species comprising the genus Mycoplasma are among the smallest living prokaryotes and are characterized by the absence of a cell wall and reduced genome size (Samuelsson and Boren, 1992) . Mycoplasmas have limited biosynthetic capabilities, and exist as commensals or parasites of plants, vertebrates, and arthropods (Razin, 1992) . Specifically in the chicken, virulent strains of M. gallisepticum cause a chronic respiratory disease syndrome in chickens and severe sinusitis in turkeys (Ley and Yoder, 1997) . Chronic respiratory disease in chickens i s characterized by exfoliation of ciliated epithelial cells, accumulation of an inflammatory exudate in the trachea, and a severe air-saculitis (Dykstra et al., 1985; Ley and Yoder, 1997) . In the reproductive system, virulent M. gallisepticum induce inflammatory lesions leading to the formation of large caseous plugs in the oviduct (Pruthi and Kharole, 1981) . Primary control of disease is through vaccination using live attenuated M. gallisepticum (Whithear, 1996) . The F strain of M. gallisepticum (termed F-strain for brevity) is used as a live vaccine; it protects the respiratory tract of vaccinates (Abd-El-Motelib and Kleven, 1993) , and alleviates egg production decreases (Branton et al., 1997) . In addition, the F-strain displaces field strains of M. gallisepticum from infected animals (Kleven et al., 1998) . Our long term goal is to understand the mechanism of
Materials and Methods
host adaptation of the F-strain to poultry, which may be related to Mycoplasma: F-strain (gift of S. H. Kleven, University of Georgia) the efficacy of the F-strain vaccine. We postulate the mechanism was propagated as described (Frey et al., 1968) . F-strain cells after of host adaptation is due to surface proteins expressed by the F-24 h culture, were washed three times in phosphate buffered strain.
saline (8.12 g Na HPO , 8.7 g NaCl, and 1.88 g NaH PO per liter) One prominent class of surface proteins expressed by M.
and used in hemagglutination inhibition experiments and for gallisepicum is encoded by the pMGA gene family. The pMGA genomic DNA extraction (below). gene family encodes hemagglutinin lipoproteins, initially identified using monoclonal antibodies (mAbs) which inhibited Genomic library construction: Genomic DNA was isolated from the hemagglutination of chicken erythrocytes by M. gallisepticum 24 h F-strain cultures as described (Keeler et al.,1996) . Cells were (Markham et al., 1992) . The mAbs recognized a 67 kDa digested using Proteinase K (Sigma Chemical Co.), and DNA lipoprotein from the virulent field strains S6 and R and a 75 kDa extracted using phenol and chloroform, followed by ethanol lipoprotein expressed by the F-strain. Peptides derived from the 67 k Da protein were sequenced and degenerate oligodeoxynucleotides were deduced from the amino acid sequence for use as hybridization probes. The clones derived from screening a genomic library prepared from M. gallisepticum S6 DNA revealed a number of open reading frames in tandem, separated by intergenic regions of about 350 bp (Markham et al., 1993) . Additional studies identified 5 pMGA genes, termed pMGA1.1 -pMGA1.5 (Markham et al., 1994) . A genomic survey of several M. gallisepticum strains indicated that the number of pMGA genes varied from 32 genes in F-strain, to 33 and 70 genes in the v irulent S6 and R strains, respectively (Baseggio et al., 1996) . We propose that adaptation of the F-strain to poultry is due to the spectrum of pMGA hemagglutinin genes expressed, which may play an important role in the binding of F-strain to host epithelia. Thus, it is critical to identify the pMGA genes expressed by the Fstrain isolate that has been used in vaccine studies for a number of y ears (Branton et al., 1984) . In this report we identify pMGA mRNAs expressed in the F-strain. This information will be used in the future to evaluate pMGA gene translation and function of the products in F-strain host colonization. (Minion et al., 1995) . The digested DNA was then size -fractionated b y centrifugation on sucrose gradients as described (Luthe, 1983) . DNA fragments (5 -8 kb) were ligated into the Eco RI restriction enzyme site of the 8 ZAPII, bacteriophage 8 vector, followed by packaging to produce infectious particles with Gigapack Gold III packaging extracts according to the manufacturer's protocol (Stratagene, La Jolla, CA). The unamplified library had a titer of 3 x 106 pfu/ml, with 1% nonrecombinants and an average insert Fig. 1 : Structure of the 8 9 phage clone compared to pMGA size of 5 kb.
genes in the genome. The pMGA genes are arranged in
Library screening: The library was plated with an equal mixture by intergenic regions containing promoter elements of E. coli strains ISM612 and XL1-blue. ISM612 has two UGA (Markham et al., 1994) . The direction of transcription i s suppressors, a prfB3 mutation blocking release factor function, and denoted by arrows. Trp T under IPTG-inducible control on a plasmid which will allow expression of mycoplasma genes containing the UGA codon GACACCACGCCATGGCAAAAGAAAGGTTC-3' and the reverse (Smiley and Minion, 1993; Minion et al., 1995) . Plates containing primer 5'-AGCACCCTCGAGAGCACCTACAGTTCTACCACC-3'; bacteria infected with recombinant phage (50,000 pfu) were underlined regions are Nco I and Xho I restriction enzyme sites overlaid with nitrocellulose filters previously soaked with IPTG (to respectively. The tuf gene forward and reverse primers are induce expression from the lacZ promoter). For immunoscreening, complementary to nucleotide positions 29 -109 and 1229 -1249 a rabbit anti -F-strain antiserum with hemmagglutinationof the tuf gene sequence, respectively (Inamine et al., 1989) . The inhibition activity was used (May et al., 1988) . Duplicate filters tuf gene -specific primers were used to assay cDNA synthesis from each plate were incubated with a 1:1024 dilution of the quality and removal of contaminating genomic DNA from RNA. rabbit antiserum, washed five times in TBST (20 mM Tris-Cl pH
The PCR consisted of 2 mM magnesium chloride, 0.2 mM each 8.0, 150 mM NaCl, and 0. 
RT-PCR:
The expression of pMGA genes at the mRNA level was for visualization of DNA fragments. evaluated as described (Glew et al., 1995) . Total RNA was prepared from 24 h cultures of F-strain using Trizol (Invitrogen,
Nucleotide sequence analysis of library phage and cDNA: The Carlsbad CA), treated with RNase-free DNAse I at 37 C (Waldo et insert from the phage clone, remaining positive through al., 1999). DNAse I was removed by incubation with a proteinadditional rounds of screening with the rabbit antisera, was binding reagent (Ambion Inc, Austin TX). Total cDNA was sequenced using dye terminator cycle sequencing using synthesized from RNA primed with random hexamers and reverse pBluescript phagemid promoter primers (Stratagene, La Jolla, CA) transcribed with SuperScript II reverse transcriptase (Invitrogen).
or internal primers (Genosys, The Woodlands TX). Sequencing Control samples for the reverse transcription were; reaction products were analyzed on an ABI Prism 310 Genetic 1.
DNAse I, RNAse A, and reverse transcriptase only, Analyzer (Applied Biosystems). The cDNAs obtained from the PCR 2.
RNA only, experiments were ligated into pT7Blue vector and sequenced 3.
RNA with DNAse I, RNAse A, and reverse transcriptase, with the T7 and U19 vector primers (Novagen, Inc. Madison, WI). 4.
RNA with DNAse I only, and The phage insert and the PCR amplified products were 5. 100 ng of F-strain genomic DNA with or without DNAse I. completely sequenced on both strands. Sequence data were The pMGA cDNAs were amplified using the following primers analyzed with MacDNASIS Pro V3.1 software (Hitachi Software (Genosys Biotechnologies, The Woodlands, TX). Forward primer Engineering America, Ltd, San Francisco, CA) and using the (pMGA1), 5'-AGTCCCGGGAGTGAAAAGAAAAAACATTTTAAAGGenBank database (National Center for Biotechnology 3' complementary to the conserved 5' region of all pMGA genes Information). Alignments of predicted amino acid sequence were analyzed to date, nucleotide positions 967 -990 and 3313 -3336 created with the Clustal W version 1.7 program (Thompson et al. , of the 9.2 and 9.3 ORF, respectively (GenBank: AF210770); 1994). underlined region is a Sma I restriction enzyme site. The reverse primer was a degenerate pMGA primer (T23), 5'-GTTAGAATTCTTYTWGCRGCWGYTAAT-3' (Glew et al., 1995) where Y=C+T, W=A+T, and R=A+G; underlined region is an Eco RI restriction enzyme site. T23 is complementary to nucleotide positions 1197 -1213 and 3543 -3559 of the 9.2 and 9.3 orf, respectively (GenBank: AF210770). An additional reverse primer (128A), 5' -CGTCTTTTCGCTTATTAGTT-3', complementary t o nucleotide positions 3994 -4014 of the 9.3 orf sequence of the phage clone 89 (GenBank: AF210770). To amplify the tuf gene of M. gallisepticum (Inamine et al., 1989) ; forward primer 5'-tandem on the M. gallisepticum chromosome, separated were analyzed on 1% agarose gels stained with ethidium bromide
Results
Genomic library screening: To detect F-strain pMGA genes, a rabbit ant -F-strain antiserum with hemagglutination -inhibition activity was used in immunoscreening. Immunoscreening o f phage-library-lifts with the antiserum yielded a phage clone, termed 89, which remained positive through additional rounds of screening, and was characterized by nucleotide sequencing (Genbank accession number AF210770). Analysis of sequence data predicted three ORF arranged in tandem within the 4.5 kb insert, termed 9.1, 9.2, and 9.3 (Fig. 1) .
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GNSSSVVGNIKTLRLGKGLNKIIISGGTQDGTNAPYIGNLTFKLMTTTSNSETNTPAEGT . : * :* * :*****:::* * : ** :* * * * ::.. (Markham et al., 1994) . The pMGA1.1 and pMGA1.2 protein from the M. gallisepticum HS strain (GenBank accession number AF275312) are denoted as pMGA1.1HS and pMGA1.2HS in the figure. The pMGA M9 protein is from the M. gallisepticum PG31 strain Liu et al . (1998) . Identical amino acids are designated by an "*". Conservative amino acid substitutions are designated by "." and : ":" Dashes indicate gaps introduced to maximize homology.
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TTAAGCAGATTTATTACTTACT-GAACTTTATATATTC-TTATATTAATAA-TAGACGTG pMGA1.1 TAAACCCGATTTATTACTTACT-GAACTTTATATATTC-TTAAATTAATAA-TAGACGTG 9.2 orf TAAACCCGATTTATTACTTAATTGAACTTTATATATTCCTTAACTTGATGAGTATGTATT * ** * ******** **** * *************** ** * ** * ** * (GAA)n 9.3 orf GTGAACGTAAGTT-ATTGA-TTAACTTTAAGTG 12 M9
TTTAACGTAAGTT-ATTGGCTTAACTTTAAGTG 12 pMGA1.1 TTTAACGTAAGTT-ATTGGCTTAACTTTAAGTG 12 9.2 orf TTTCATACAAATTCATCGATTCAACTTTAAGTG 15 * * ** ** ** * * *********** 3337 3396 9.3 orf TTTGTTAGTTTATTAGGTATTGGTTCGTTTGTAATGGTAGCTGCAGCTAGTTGTACTTCA 1-1 cDNA TTTGTTAGTTTATTAGGTATTGGTTCGTTTGTAATGGTAGCTGCAGCTAGTTGTACTTCA 1-2 cDNA TTTGTTAGTTTATTAGGTATTGGTTCGTTTGTAATGGTAGCTGCAGCTAGTTGTACTTCA 1-3 cDNA TTTGTTAGTTTATTAGGTATTGGTTCGTTTGTAATGGTAGCTGCAGCTAGTTGTACTTCA 1-4 cDNA TTTGTTAGTTTATTAGGTATTGGTTCGTTTGTAATGGTAGCTGCAGCTAGTTGTACTTCA ************************************************************ 3397 3450 9.3 orf GCAGCTACACCAACTCCAAACCCTGAACCAAA------TCCAAACCCTGAACCAAAACCA 1-1 cDNA GCAGCTACACCAACTCCAAACCCTGAACCAAA------TCCAAACCCTGAACCAAAACCA 1-2 cDNA GCAGCTACACCAACTCCAAACCCTGAACCAAAACCAAATCCAAACCCTGAACCAAAACCA 1-3 cDNA GCAGCTACACCAACTCCAAACCCTGAACCAAA------TCCAAACCCTGAACCAAAACCA 1-4 cDNA GCAGCTACACCAACTCCAAACCCTGAACCAAAACCAAATCCAAACCCTGAACCAAAACCA ******************************** ********************** 3451 3510 9.3 orf GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT 1-1 cDNA GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT 1-2 cDNA GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT 1-3 cDNA GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT 1-4 cDNA GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT ************************************************************ 3511 3543 9.3 orf GGTCAAAATATGATGGATTCTGCAGCTCAAGA 1-1 cDNA GGACAAAATATGATGGATTCTGCAGCTCAAGA 1-2 cDNA GGACAAAATATGATGGATTCTGCAGCTCAAGA 1-3 cDNA GGACAAAATATGATGGATTCTGCAGCTCAAGA 1-4 cDNA GGACAAAATATGATGGATTCTGCAGCTCAAGA ** ***************************** Pharr et al .: pMGA cDNAs of M. gallisepticum F-strain 68 Fig. 3 : Nucleotide sequence alignment of the 9.2 and 9.3 intergenic regions with the intergenic regions of pMGA genes pMGA1.1 and M9 which are expressed at the protein level in M. gallisepticum strains S6 (Markham et al., 1994) and PG31 (Liu et al., 1998) , respectively. Identical nucleotides are designated by an "*". Dashes indicate gaps introduced to maximize homology. 3396 9.3 orf TTTGTTAGTTTATTAGGTATTGGTTCGTTTGTAATGGTAGCTGCAGCTAGTTGTACTTCA 13A3 cDNA TTTGTTAGTTTATTAGGTATTGGTTCGTCTGTAATGGTAGCTGCAGCTAGTTGTACTTCA 13-5 cDNA TTTGTTAGTTTATTAGGTATTGGTTCGTTTGTAATGGTAGCTGCAGCTAGTTGTACTTCA 13 cDNA TTTGTTAGTTTATTAGGTATTGGTTCGTTTGTAATGGTAGCTGCAGCTAGTTGTACTTCA 14 DNA TTTGTTAGTTTATTAGGTATTGGTTCGTTTGTAATGGTAGCTGCAGCTAGTTGTACTTCA 14-5 DNA TTTGTTAGTTTATTAGGTATTGGTTCGTTTGTAATGGTAGCTGCAGCTAGTTGTACTTCA 14A3 DNA TTTGTTAGTTTATTAGGTATTGGTTCGTTTGTAATGGTAGCTGCAGCTAGTTGTACTTCA **************************** ******************************* 3397 3450 9.3 orf GCAGCTACACCAACTCCAAACCCTGAACCAAA------TCCAAACCCTGAACCAAAACCA 13A3 cDNA GCAGCTACACCAACTCCAAACCCTGAACCAAAACCAAATCCAAACCCTGAACCAAAACCA 13-5 cDNA GCAGCTACACCAACTCCAAACCCTGAACCAAAACCAAATCCAAACCCTGAACCAAAACCA 13 cDNA GCAGCTACACCAACTCCAAACCCTGAACCAAA------TCCAAACCCTGAACCAAAACCA 14 DNA GCAGCTACACCAACTCCAAACCCTGAACCAAA------TCCAAACCCTGAACCAAAACCA 14-5 DNA GCAGCTACACCAACTCCAAACCCTGAACCAAA------TCCAAACCCTGAACCAAAACCA 14A3 DNA GCAGCTACACCAACTCCAAACCCTGAACCAAAACCAAATCCAAACCCTGAACCAAAACCA ******************************** ********************** 3451 3510 9.3 orf GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT 13A3 cDNA GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT 13-5 cDNA GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT 13 cDNA GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT 14 DNA GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT 14-5 DNA GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT 14A3 DNA GATCCAATGCCAAACCCTCCTAGTGGTGGTATGAATGGTGGAGATATTAATCCAGGTGGT ************************************************************ 3511 3570 9.3 orf GGTCAAAATATGATGGATTCTGCAGCTCAAGAATTAACTGCCGCTAGAACTGCTTTAACT 13A3 cDNA GGACAAAATATGATGGATTCTGCAGCTCAAGAATTAACTGCCGCTAGAACTGCTTTAACT 13-5 cDNA GGACAAAATATGATGGATTCTGCAGCTCAAGAATTAACTGCCGCTAGAACTGCTTTAACT 13 cDNA GGACAAAATATGATGGATTCTGCAGCTCAAGAATTAACTGCCGCTAGAACTGCTTTAACT 14 DNA GGACAAAATATGATGGATTCTGCAGCTCAAGAATTAACTGCCGCTAGAACTGCTTTAACT 14-5 DNA GGACAAAATATGATGGATTCTGCAGCTCAAGAATTAACTGCCGCTAGAACTGCTTTAACT 14A3 DNA GGACAAAATATGATGGATTCTGCAGCTCAAGAATTAACTGCCGCTAGAACTGCTTTAACT ** ********************************************************* 3571 3630 9.3 orf AGTTTGTTAGCTAGCAAGAACGCAAATATTGAGATGTACTCTGACTATGCAAAAATTCAG 13A3 cDNA AGTTTGTTAGCTAGCAAGAACGCAAATATTGAGATGTACTCTGACTATGCAAAAATTCAG 13-5 cDNA AGTTTGTTAGCTAGCAAGAACGCAAATATTGAGATGTACTCTGACTATGCAAAAATTCAG 13 cDNA AGTTTGTTAGCTAGCAAGAACGCAAATATTGAGATGTACTCTGACTATGCAAAAATTCAG 14 DNA AGTTTGTTAGCTAGCAAGAACGCAAATATTGAGATGTACTCTGACTATGCAAAAATTCAG 14-5 DNA AGTTTGTTAGCTAGCAAGAACGCAAATATTGAGATGTACTCTGACTATGCAAAAATTCAG 14A3 DNA AGTTTGTTAGCTAGCAAGAACGCAAATATTGAGATGTACTCTGACTATGCAAAAATTCAG ************************************************************ 3631 3690 9.3 orf AATACTCTAATAGCTGCATACACAACGGCAGAACAAACTTCTCAAAATTCATCTGCTACA 13A3 cDNA AATACTCTAATAGCTGCATACACAACGGCAGAACAAACTTCTCAAAATTCATCTGCTACA 13-5 cDNA AATACTCTAATAGCTGCATACACAACGGCAGAACAAACTTCTCAAAATTCATCTGCTACA 13 cDNA AATACTCTAATAGCTGCATACACAACGGCAGAACAAACTTCTCAAAATTCATCTGCTACA 14 DNA AATACTCTAATAGCTGCATACACAACGGCAGAACAAACTTCTCAAAATTCATCTGCTACA 14-5 DNA AATACTCTAATAGCTGCATACACAACGGCAGAACAAACTTCTCAAAATTCATCTGCTACA 14A3 DNA AATACTCTAATAGCTGCATACACAACGGCAGAACAAACTTCTCAAAATTCATCTGCTACA ************************************************************ 3691 3750 9.3 orf CTAGAACAAGTTAAAAACGCTACATCAGCTTTACAAACAGCTATTAATACGGCTAATAGT 13A3 cDNA CTAGAACAAGTTAAAAACGCTACATCAGCTTTACAAACAGCTATTAATACGGCTAATAGT 13-5 cDNA CTAGAACAAGTTAAAAACGCTACATCAGCTTTACAAACAGCTATTAATACGGCTAATAGT 13 cDNA CTAGAACAAGTTAAAAACGCTACATCAGCTTTACAAACAGCTATTAATACGGCTAATAGT 14 DNA CTAGAACAAGTTAAAAACGCTACATCAGCTTTACAAACAGCTATTAATACGGCTAATAGT 14-5 DNA CTAGAACAAGTTAAAAACGCTACATCAGCTTTACAAACAGCTATTAATACGGCTAATAGT 14A3 DNA CTAGAACAAGTTAAAAACGCTACATCAGCTTTACAAACAGCTATTAATACGGCTAATAGT ************************************************************ 3751 3809 9.3 orf AATAAACAAAAA-TTTGATCAAGATCATAGTAATCTATTAATGTCATATAAAAACTTAAT 13A3 cDNA AATAAACAAAAA-TTTGATCAAGATCATAGTAATCTATTAATGTCATATAAAAACTTAAT 13-5 cDNA AATAAACAAAAA-TTTGATCAAGATCATAGTAATCTATTAATGTCATATAAAAACTTAAT 13 cDNA AATAAACAAAAAATTTGATCAAGATCATAGTAATCTATTAATGTCATATAAAAACTTAAT 14 DNA AATAAACAAAAA-TTTGATCAAGATCATAGTAATCTATTAATGTCATATAAAAACTTAAT 14-5 DNA AATAAACAAAAA-TTTGATCAAGATCATAGTAATCTATTAATGTCATATAAAAACTTAAT 14A3 DNA AATAAACAAAAA-TTTGATCAAGATCATAGTAATCTATTAATGTCATATAAAAACTTAAT ************ *********************************************** 3810 3868 9.3 orf GGCTACTCTTGCTAAAAAA-GAAACTACTGTAATGACATTAAAAGATCCAAAATATAGCG 13A3 cDNA GGCTACTCTTGCTAAAAAAAGAAACTACTGTAATGACATTAAAAGATCCAAAATATAGCG 13-5 cDNA GGCTACTCTTGCTAAAAAA-GAAACTACCGTAATGACATTAAAAGATCCAAAATATAGCG 13 cDNA GGCTACTCTTGCTAAAAAA-GAAACTACTGTAATGACATTAAAAGATCCAAAATATAGCG 14 DNA GGCTACTCTTGCTAAAAAA-GAAACTACTGTAATGACATTAAAAGATCCAAAATATAGCG 14-5 DNA GGCTACTCTTGCTAAAAAA-GAAACTACTGTAATGACATTAAAAGATCCAAAATATAGCG 14A3 DNA GGCTACTCTTGCTAAAAAA-GAAACTACTGTAATGACATTAAAAGATCCAAAATATAGCG ******************* ******** ******************************* 3869 3928 9.3 orf CAATTTTGGATCAAATTAATGGTGTATCTTGTAAAGGTGAAGAGCTTGTTCAACATACAT 13A3 cDNA CAATTTTGGATCAAATTAATGGTGTATCTTGTAAAGGTGAAGAGCTTGTTCAACATACAT 13-5 cDNA CAATTTTGGATCAAATTAATGGTGTATCTTGTAAAGGTGAAGAGCTTGTTCAACATACAT 13 cDNA CAATTTTGGATCAAATTAATGGTGTATCTTGTAAAGGTGAAGAGCTTGTTCAACATACAT 14 DNA CAATTTTGGATCAAATTAATGGTGTATCTTGTAAAGGTGAAGAGCTTGTTCAACATACAT 14-5 DNA CAATTTTGGATCAAATTAATGGTGTATCTTGTAAAGGTGAAGAGCTTGTTCAACATACAT 14A3 DNA CAATTTTGGATCAAATTAATGGTGTATCTTGTAAAGGTGAAGAGCTTGTTCAACATACAT ************************************************************ 3929 3988 9.3 orf TAGATCCAGTTAGTGGAATTGTTCCTGCTGCTAATACAATCACAGAAGAGATTACTAAGA 13A3 cDNA TAGATCCAGTTAGTGGAATTGTTCCTGCTGCTAATACAATCACAGAAGAGATTACTAAGA 13-5 cDNA TAGATCCAGTTAGTGGAATTGTTCCTGCTGCTAATACAATCACAGAAGAGATTACTAAGA 13 cDNA TAGATCCAGTTAGTGGAATTGTTCCTGCTGCTAATACAATCACAGAAGAGATTACTAAGA 14 DNA TAGATCCAGTTAGTGGAATTGTTCCTGCTGCTAATACAATCACAGAAGAGATTACTAAGA 14-5 DNA TAGATCCAGTTAGTGGAATTGTTCCTGCTGCTAATACAATCACAGAAGAGATTACTAAGA 14A3 DNA TAGATCCAGTTAGTGGAATTGTTCCTGCTGCTAATACAATCACAGAAGAGATTACTAAGA ************************************************************ VKRKNILKFVSLLGIGSFVMVAAASCTSAATPTPNPEP--NPNPEPKPDPMPNPPS ************************************** **************** The cDNA clones (1-1, 1-2, 1-3, and 1-4) were PCR amplified with primers pMGA1 and T23. B.
The cDNA (13A3, 13-5, and 13) and genomic (14, 14-5, and 14A3) clones were obtained with primers pMGA1 and 128A from M. gallisepticum F-strain. C.
N-terminal predicted amino acid sequence derived from the PCR amplified cDNA and genomic clones. The sequence from the 9.3 ORF is used as the prototype. Identical nucleotides are designated by an "*".
Nucleotide sequence analysis: The 9.1 ORF represents the Cmembers (Baseggio et al., 1996; Markham et al., 1994) . Variation terminal region of a pMGA gene and the predicted amino acid in the number of GAA repeats is a mechanism of transcriptional sequence shows an identity of 92% in the C-terminal region with regulation for the pMGA genes; (GAA)12 are present in the the pMGA1.1 protein of M. gallisepticum HS strain (GenBank: intergenic regions of those pMGA genes that are expressed (Glew AF275312) (Fig. 2A) . The 9.2 ORF is the largest ORF (2.0kb) et Liu et al., 1998) . (GAA)12 in the intergenic region 5' contained in the 89 insert, and is the full coding sequence of a to the 9.3 ORF suggests that the 9.3 ORF is expressed in the FpMGA gene ( Fig. 1 and Fig. 2B ). The 9.2 ORF has an overall strain. amino acid identity of 66% with the pMGA1.4 protein of M. gallisepticum S6 strain, and 50% identity to the 9.1 ORF in the CExpression of pMGA gene mRNA: The PCR primers pMGA1 and terminal region. At the opposite (or T7) end of the insert , the 9.3 T23 d esigned complementary to regions conserved among all ORF encodes the N-terminal part of a pMGA gene (Fig. 1) . The pMGA family members and were used to amplify cDNA derived complete coding sequence of the 9.3 ORF was obtained by PCR from F-strain total RNA. The pMGA1 and T23 primers resulted in amplification of genomic DNA. The predicted amino acid a 247 bp cDNA product from which the nucleotide sequence of 4 sequence of the complete 9.3 ORF has 96% identity with the cDNAs was obtained. The nucleotide sequence of the cDNA pMGA1.2 protein of M. gallisepticum HS strain (Fig. 2B) .
clones denoted as 1-1, 1-2, 1-3, and 1-4 excluding the primer The 8 9 ORF are separated by two intergenic regions of 332 bp sequences (Fig. 4A) . The cDNA sequences are most similar to the and 333 bp located 5' to the 9.2 and 9.3 orf, respectively, a s 9.3 ORF sequence; except for a nucleotide change at position illustrated in the nucleotide sequence alignment of intergenic 3513 where the 9.3 ORF sequence differs from the PCR amplified regions (Fig. 3) . The intergenic regions 5' to the 9.2 and 9.3 ORF sequences. Our cDNA sequences were divided into two groups; contain 15 and 12 copies of the GAA trinucleotide repeats which one group having a repeat of the 6 base pairs "AACCAAA" at the are c haracteristic of the intergenic regions of pMGA family N-terminus of the cDNA, and the other group lacking the repeat (as with the 9.3 ORF genomic library clone sequence, nucleotide strain used in our studies to in vitro culture (99 passages above the positions 3423 -3428 of the 9.3 ORF, Fig. 4A ). To confirm that unknown level) has selected for expression of the variant 9.3 ORF the cDNAs arose from the 9.3 ORF in the genome of the F-strain, -like cDNAs in place of the dominant pMGA gene product cDNA and genomic DNA were prepared from a fresh culture of the detected in the F-strain by Glew et al. (1995 (2000) showed that two types of pMGA1.1/1.2 genes could b e strain). Three cDNA and three genomic clones were sequenced distinguished in different strains based the presence or absence from t he 702 bp product (Fig. 4B) . The PCR amplified cDNA of a repeat sequence in the N-terminal proline-rich region. The sequences only differed from the 9.3 ORF sequence by a T to C 9.3 ORF -like cDNAs we identified differed from each other by a change at nucleotide positions 3366 and 3838, and an additional short sequence of 6 bp in the proline-rich region. Identical base p air (A) at nucleotide positions 3762 and 3829, probably sequences to both variants were also amplified from genomic Taq polymerase fidelity errors. The genomic sequences were DNA. It is not clear whether two highly similar genes are present identical to the 9.3 ORF except for a change from T to A a t in the F-strain genome, or whether only one 9.3 ORF -like gene position 3513. Two of the cDNA clones and one genomic clone is present which shows heterogeneity in the N-terminal region in showed the repeat sequence "AACCAAA" at nucleotide positions the F-strain population. 3423 -3428 (Fig. 4B) . The presence of the nucleotide sequence Our data predicts two additional amino acids are encoded in the repeat predicts two additional amino acids (Proline and Lysine) in the protein at residue positions 39 and 40 (Fig. 4C ).
Discussion
The F-strain is used as a live vaccine by the poultry egg layer industry (Branton et al., 2000) , and has the desirable quality of long term persistence (Kleven, 1981) . The pMGA genes occupy a significant portion of the genome in various M. gallisepticum strains (Baseggio et al., 1996) and the pMGA ORFs characterized to date lack in-frame stop codons suggesting they should b e capable of expression (Markham et al., 1994) . The importance of pMGA gene products in host colonization and persistence has been proposed (Markham et al., 1993) , and homologs of pMGA genes h ave been identified in two other species of poultry mycoplasmas (Noormohammadi et al., 1998; Markham et al., 1999) . Therefore, we considered it critical to identify and characterize the pMGA hemagglutinin genes expressed by Fstrain cells to understand the persistence of this vaccine i n chickens. To identify pMGA genes, we constructed a 8 ZAPII Fstrain genomic library and immunoscreened this with rabbit polyclonal antibody raised against M. gallisepticum F-strain surface antigens (May et al., 1988) . Rabbit antiserum with hemagglutination -inhibition activity identified a genomic library clone with two partial, and one complete, ORFs with significant homology to the pMGA hemagglutinin gene family of M. gallisepticum. A specific number of GAA repeats, (GAA) n = 12, is found in the promoter region of expressed pMGA genes (Baseggio et al., 1996; Markham et al., 1998; Glew et al., 1998) . Recent studies of pMGA transcription propose that the length of the repeat region affects the distance between two DNA sequences that bind a protein responsible for pMGA gene transactivation (Liu et al., 2000 (Liu et al., , 2002 . Sequencing of the intergenic regions 5' of our 9.2 and 9.3 ORF revealed a series of GAA trinucleotide repeats 5' of the coding regions, and the 12 GAA repeats 5' of the 9.3 ORF suggested that the pMGA gene is expressed in F-strain. The cDNAs obtained with our RT-PCR studies were, not surprisingly, more similar to the 9.3 ORF sequence we obtained than to other pMGA gene sequences reported to date. The Nterminal region of the predicted amino acid sequence of our 9.3 ORF cDNA sequence differs from the N-terminal sequence reported by peptide sequencing of a pMGA protein of the F-strain by others (Glew et al., 1995) . It is possible that the 9.3 ORF -like cDNAs we detected represent a variant pMGA gene(s) expressed in the F-strain population. Noteably, Glew et al. (1995) , identified 3 different pMGA genes in addition to the predominantly expressed pMGA1.1 mRNA species the M. gallisepticum S6 strain population. Another possibility is that the adaptation of the Fproline rich region ( Fig. 4B and 4C ). Proline rich regions o f proteins can form elongated structures that may function i n protein -protein interactions (Kay et al., 2000) . Because pMGA proteins are probably attached to the mycoplasmal cell membrane at the N-terminus by a lipid moiety (Markham et al., 1993) , we speculate that the N-terminal proline rich region o f pMGA proteins are involved in protein -protein interactions at the cell surface. One possible function would be to sequester host proteins at the mycoplasmal cell surface for digestion by cellassociated proteases for subsequent amino acid transport into the mycoplasma cell for the nutrition. Experimental evidence for peptide binding by a mycoplasma lipoprotein adhesin is reported (Henrich et al., 1999) . In this regard, if both cDNAs identified in this study are translated, then such an auxiliary function of pMGA adhesins may play a role in the persistence of F-strain in the respiratory tract of chickens.
